P492 Use of bowel ultrasound to assess disease activity in Crohn’s disease patients after induction therapy with infliximabC Frias Gomes, Carolina Palmela, Sara Monteiro et al.|Journal of Crohn s and Colitis|2020Cited by 2
P499 Accessing ultrasonographic transmural healing in patients with Crohn’s disease after induction therapy with infliximab: should we aim for higher infliximab trough levels?B Morão, Carolina Palmela, C Frias Gomes et al.|Journal of Crohn s and Colitis|2022Cited by 1
P152 Bowel ultrasound as an early monitoring tool to assess disease activity in Crohn’s disease patients after induction therapy with infliximabB Morão, Carolina Palmela, C Macedo et al.|Journal of Crohn s and Colitis|2021Cited by 0
P145 Ultrasonographic parameters associated with mucosal healing 1 year after infliximab therapy in Crohn’s Disease: a multicentric and prospective studyCatarina Nascimento, Carolina Palmela, C Frias Gomes et al.|Journal of Crohn s and Colitis|2022Cited by 0
P375 Faecal calprotectin variation after induction therapy with infliximab to predict clinical, endoscopic and ultrasonographic remission in Crohn’s disease patientsJoana Revés, Carolina Palmela, B Morão et al.|Journal of Crohn s and Colitis|2022Cited by 0